Biomarkers for inflammatory skin disease
US11584961B2 · kind B2 · utility
0Cited by
34References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2019 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | Jan 6, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing an inflammatory skin disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.